{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-001581","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2024-01-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.064654+00:00","generated_at":"2026-06-06T21:50:01.278424+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Puma Biotechnology presents at B. Riley Oncology Conference; no material new information disclosed.","bullets":["Presentation at B. Riley Securities 4th Annual Oncology Conference on January 18, 2024.","Chairman, President and CEO Alan H. Auerbach to present.","Exhibit 99.1 presentation not included as extractable text; specifics unavailable.","No financial or operational updates disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-001581","json":"https://secwatch.observer/filing/0001437749-24-001581.json","markdown":"https://secwatch.observer/filing/0001437749-24-001581.md","text":"https://secwatch.observer/filing/0001437749-24-001581.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924001581/0001437749-24-001581-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924001581/pbyi20240116_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:50:01.278424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}